Spark Biomedical
1 known investors
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.
BiotechDigital HealthHardwareHealthtechMedical Devices
Founders & leadership
DP
Daniel PowellPresident & Chief Executive Officer
AC
Alejandro Covalin, PhDChief Technology Officer
NK
Navid Khodaparast, PhDChief Science Officer
Investors · 1
In the news
- Spark Biomedical Awarded Funding from Wellcome Leap for Women’s Health Innovationfinance.yahoo.com · 2025
- Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapiesglobenewswire.com · 2025
- Dallas' Spark Biomedical Raises $15M Series A to Advance Its Wearable Neurostimulation Therapies » Dallas Innovatesdallasinnovates.com · 2025
- Spark Biomedical Raises $15M in Series A Fundingfinsmes.com · 2025
- Spark Biomedical - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Spark Biomedical - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021